An evaluation of fevipiprant for the treatment of asthma: a promising new therapy?-Reference-Cited by-同舟云学术

An evaluation of fevipiprant for the treatment of asthma: a promising new therapy?

Published:2018-11-03 Issue:18 Volume:19 Page:2087-2093
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Murillo Juan Carlos¹,Dimov Ves²,Gonzalez-Estrada Alexei³^ORCID

Affiliation:

1. Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic , Scottsdale, Arizona, USA

2. Department of Allergy and Clinical Immunology, Cleveland Clinic , Weston, Florida, USA

3. Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic , Jacksonville, Florida, USA

Funder

not

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1540589

Reference61 articles.

1. World Health Organization (WHO) asthma fact sheet . World Health Organization. 2017. [cited 2018 May 13 ]. Available from: http://www.who.int/en/news-room/fact-sheets/detail/asthma

2. Global Initiative for Asthma (GINA) Report, Global Strategy for Asthma Management and Prevention .GINA 2018. [cited 2018 May 13 ]. Available from: http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/

3. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

4. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey

5. Severe asthma: from characteristics to phenotypes to endotypes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, safety, and tolerability of TQC3564, a novel CRTh2 receptor antagonist: report of the first-in-human single- and multiple-dose escalation trials in healthy Chinese subjects;Expert Opinion on Investigational Drugs;2022-05-18

2. Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation;Frontiers in Physiology;2021-07-15

3. Asthma Phenotypes and Current Biological Treatments;Asthma [Working Title];2021-04-30

4. The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy;International Journal of Molecular Sciences;2020-03-08

5. Eosinophilic vs. Neutrophilic Asthma;Current Pulmonology Reports;2020-02-13